ML20141J096
| ML20141J096 | |
| Person / Time | |
|---|---|
| Issue date: | 08/19/1995 |
| From: | Siegel B NRC |
| To: | Stewart Schneider NRC |
| Shared Package | |
| ML20007J296 | List:
|
| References | |
| FRN-62FR4120, RULE-PR-20, RULE-PR-35 AE41-2-021, AE41-2-21, NUDOCS 9708140392 | |
| Download: ML20141J096 (8) | |
Text
_ - _ _ _ _ _ _ - _ _ _ _ - _ - _ _
PDL A E4l-x 0s From: "Barry Siegel" ("SIECELB0MIRLINK.WUSTL.EDU")
To: sxs49nrc. gov Date: Saturday, August 19, 1995 2:00 pm
Subject:
Patient Release Rule (SMTP Idf: 26215)
Stewart:
I have no trouble with the text you sent to me on Friday concerning the information I had supplied to NRC.
Where does the rule stand? Has the language changed since the last version you sent to me?
BAS l
l O
e
\
9781g392970807
]
20 62FR4120 PDR cinetst<f.o~69 a azy
c PDR jE 41-5 -
FORM 386 U.S. NUCLEAR REGULATORY COMMISSION DATE
_ xl n AN', t
'm_,,.._..
_Ikasilpasiu.'Li TELECOPIER TRANSMITTAL l@ {
WE, h hM WARNING: Most facsimile machines produce copies on thermal paper. The image produced is highly unstable and will deteriorate significantly in a few years. Reproduce copies onto plain paper prior to filing as a record.
TO
)f. h Q,h S)6Y b b-P4AME AND LQCATION OF COMPANYfff other than ~NRC)
Jy} /dL 1 / / Y 4. $ ([ t.J g)'j g
A ,gg7~c{ g fb, U
&( . ( o u ,9, 1 Y)a-1 i
TELECOPY NUMBED VERIFICATION NUMBEH 31t/ -362 -28o6 FROM NAME TELEPHONE MAIL STOP TELECOPY DATA NUMBER OF PAGES PRIORITY r IMMEDLATE
~~
THIS PAGE + PAGES = - TOTAL OTHER (Specify)
SPECIAL INST RUCTIONS
{%h' bO'lk'L D i( kv " I h . d? N '
( t v3 I bc / Wc rywc h p cse 5aw
%5 C n6uuf A
' Ten h c ownnTs. W A N'd i m 4 mo,( ( o w-gc i nJ) ob
/ Y.,NG% iA'v A'2.T.
PROBLEMS DISPOSITION OF ORIGINAL If any problems occur or 6f you do not recorve all the pages, call. After telecopy has been sent. process the original as toquested below. (F none are chocaed, the originaf wM be cNscarded.)
RETURN TO SENDER PHONE CALL AND SENDER WILL PICK UP DISCARD PROCESSED BY (INmALS) VERIFIED BY (INmALS) vcKwwasnasa mNTto oN acycuD PAPER
-b
[ Authority: Secs. 81, 161, 182, 183, 68 Stat. 935, 948, 953, 954, as amended (42 U.S.C. 2111, 2201, 2232, 2233); sec. 201, 88 Stat. 1242, as amended-'(42 U.S.C. 5841).
1
- 6. In Section 35.8, paragraph (b) is revised to read as follows:
i 35.8 Information collection requirements:- OM8 approval.
(b) The approved information collection requirements contained in this part appear in il 35.12, 35.13, 35.14, 35.21, 35.22, 35.23, 35.27, 35.29, 35.13, 35.50, 35.51, 35.53, 35.59, 35.60, 35.61, 35.70, 35.75, 35.80, 35.92, 35.204, 35.205, 35.310, 35.315, 35.404, 35.406, 35.410, 35.415, 35.606, 35.610, 35.615, 35.630, 35.632, 35.634, 35.636, 35.641, 35.643, 35.645, and 35.647.
O' * * * * *
- 7. Section 35.75'is revised to read as follows:
i35.75 Release of individuals containing radiopharmaceuticals or permanent implants.
(a) The licensee may authorize the release from its control any individual who has been administered radiopharmaceuticals or permanent implants containing radioactive material if the total effective dose i O 56 Attachment 1
e b
equivalent to any other individual from exposure to the released individual is u "j not likely to exceed 5 millisieverts (0.5 rem).*
(b) The licensee shall provide the released individual with l instructions, including written instructions, on actions recommended to maintain doses to other individuals ALARA if the total effective dose i equivalent to any other individual is likely to exceed 1 mil 11 sievert (0.1 rem). If the released individual may be breast-feeding an infant or child, the instructions shall also include (1) guidance on the interruption of breast-feeding and (2) information on the consequences of failure to follow the guidance.
(c) The licensee shall maintain a record of the basis for authorizing the release of an individual, for 3 years after the date of release, if the total effective dose equivalent is calculated (1) using an activity other than the activity administered, (2) using an occupancy factor other than 0.25 at 1 meter, (3) using the biological or effective half-life, or (4) considering the shielding by tissue.
(d) The licensee shall maintain a record, for 3 years after the date of release, that instructions were provided to a breast-feeding woman if the radiation dose to the infant or child from continued breast-feeding could result in a total effective dose equivalent exceeding 5 millisieverts (0.5 rem).
5 35.315 [ Amended]
' Regulatory Guide 8.39, " Release of Patients Administered Radioactive Materials," describes methods for calculating doses to other individuals and O
contains tables of activities not likely to cause doses exceeding 5 millisieverts (0.5 rem).
57 Attachment 1
TRANSMISSION REPORT 08.21.1995 15:09 C\ HR C-R E s t'R A / R P H E B REMOTE ID FAGE5 RESULT DATE TIME DURRil0H MODE 08.21 15806 02'57" 13143622806 G3 3 0.K.
l l
-\
PDR AE- #;u 3 FOHM 366 U.S. NUCLEAR REGULATORY COMMISSION DAT E TELECOPIER TRANSMITTAL WE 1 h f 47 WARNING: Most facsimile machines produce copies on thermal paper. The image produced is highip unstable and will deteriorate significantly in a few years. Reproduce copies onto plain paper prior to filing as la record.
TO l fs Ch ( ( }q &
NAME AND LOCATION OF COMPANY (if other than NRC) i riv O ofE. A ; o 4 kh 9r. 6c4s ,MD-TELECOPY NUMBER VERIF ICATiON NUME9ER 31'I-362.-280(o' __
^
FROM NAME TELEPHONE MAIL STOP M ~6 W O N b O N blD#1b M If15-b7 W TELECOPY DATA NUMBER OF PAGES PRIORITY IMMEDIATE THIS PAGE + _,
k PAGES = b TOTAL OTHER (SpecHy)
SPECIAL INSTRUC160NS NCAG S % \ik C'$ N'h f a petagtychase (wkL-fdbhM
_7 PROBLEMS DISPOSITION OF ORIGINAL If any probierns occur or d you do not receive all the pages, call. After telecopy has been sont, process the original as fequested below. (if none are checked, the original dlf be discaded)
RETURN TO SENDER EPHONE CALL AND SENDER WILL PICK UP DISCARD PROCESSED BY (lNmALS) VERIFIED BY (INMALS)
Nit FCW4M 366 (12 Da PHINTE D ON HECYCLLD PAPER
t l 35.75 = Release of individuals containing radiopharmaceuticals or permanent
-O -implants. _ .
(a) The licensee may autliorize the release from its control any
, individual who- has been administered radiopharmaceuticals or permanent implants containing radioactive material if the total effective dose
- equivalent to any other individual from exposure to the released individual is l _not likely to exceed 5 millisieverts (0.5 rem).*
(b) The licensee shall provide the released individual with instructions, including written instructions, on actions recommended to maintain doses to other individuals ALARA if the total effective dose equivalent to any other individual is likely to exceed 1 mil 11 sievert (0.1 rem). If the dose to a breast-feeding infant or child could exceed 1 mil 11 sievert (0.1 rem) assuming thert were no interruption of breast feeding, the instructions shall also include 1) guidance on-the interruption of breast-feeding and (2) information on the c(onsequences of failure.to follow the guidance.
(c) The licensee shall maintain a record of the basis for authorizing the release of an individual, for 3 years after the date of release, if the '
total effective dose equivalent is calculated l the activity administerei, (2) using an occupan(cy) using factor an activity other other than 0.25 at than 1 meter, (3) using the b,ological or effective half-life, or (4) considering the shielding by tiss%.
(d release,)that instructions were provided to a breast-feeding woman if theThe license radiation dose to the infant or child from continued breast-feedino could result in a total effective dose equivalent exceeding 5 millisieverts (0.5 rem).
' Regulatory Guide 8.39, " Release of Patients Administered Radioactive Materials" 1995), describes methods for calculating doses to other
. individuals (and contains. tables of activities not likely to cause doses O exceeding 5 millisieverts (0.5 rem).
58 Attachment 1
TRANSMISSION REPORT 09.08.1995 13:18 J.
HRL-PE$DRA/RPHEB DATE YlME DUP 4110H REMOTE ID MODE F'RGES WESULT 09.99 13816 01'89" 13843622806 63 2 0.t.
l I
(
_ _ _ _ _